Viking's weight-loss pill data disappoints, shares sink – Reuters

Written by

admin

in

  1. Viking’s weight-loss pill data disappoints, shares sink  Reuters
  2. This Weight-Loss Stock Is Down 40%. It Lowers the Risks for Eli Lilly and Novo Nordisk.  Barron’s
  3. Viking’s oral pill reduces up to 12.2% weight but shares slump on higher patient exits  Reuters
  4. Viking Therapeutics shares plunge on weight loss trial tolerability concerns  Proactive financial news
  5. Why Viking Therapeutics Shares Took a Dive  TipRanks

Continue Reading

More posts